Source - The artificial intelligence (AI) scores for UCB and Samsung Bioepis have been updated on GlobalData’s Drug Development Thematic Scorecard as a result of new partnerships. UCB: Score Increased from 3 to 4 On 23 February, UCB announced it had expanded an existing collaboration with Microsoft to use the latter’s AI, Cloud, and computational Read More

Read More
Artificial Intelligence